CD19-CAR-T Cells in Patients With R/R B-ALL

Clinical trial NCT03574168 · UNKNOWN

Trial details

NCT number: NCT03574168
Sponsor: Bioceltech Therapeutics, Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia

Start date: 2018-07-20
Primary completion: 2019-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.